Product Code: ETC6188129 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The pharmaceutical granulation equipment market in Australia is driven by increasing investments in solid dosage manufacturing and advancements in granulation technology, including dry, wet, and melt granulation methods. Demand for high-efficiency and continuous granulators is growing due to their ability to produce uniform particle sizes and enhance bioavailability. Regulatory compliance with GMP standards continues to influence equipment upgrades across Australia pharmaceutical manufacturing units.
The Australia pharmaceutical granulation equipment market is experiencing increased adoption due to the growing demand for advanced drug formulations, particularly in controlled-release and solid dosage forms. The trend is driven by innovations in wet and dry granulation technologies that ensure uniformity and improved bioavailability. Manufacturers are investing in automated, energy-efficient systems to meet Good Manufacturing Practice (GMP) standards and boost production scalability.
This market is highly capital-intensive, limiting access for smaller pharmaceutical manufacturers in Australia. The technology-intensive nature of granulation equipment also demands skilled technicians, who are in short supply. Rapid technological advancements can render equipment obsolete quickly, posing financial risks for investors.
Advanced equipment markets like granulation machinery are supported through technology modernization grants and depreciation incentives for capital machinery. The Australia government actively promotes investment in pharmaceutical equipment manufacturing to enhance domestic capability.
Granulation equipment is covered under Australia manufacturing and machinery regulations. Pharmaceutical-specific machinery must be validated for GMP compliance, and the TGA enforces inspections to ensure that granulation equipment does not introduce contamination or variability in drug products. Policies also focus on the automation and digital control aspects of granulation equipment, aligning with the Industry 4.0 roadmap.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmaceutical Granulation Equipment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharmaceutical Granulation Equipment Market - Industry Life Cycle |
3.4 Australia Pharmaceutical Granulation Equipment Market - Porter's Five Forces |
3.5 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume Share, By Mechanism, 2021 & 2031F |
3.7 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Pharmaceutical Granulation Equipment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Pharmaceutical Granulation Equipment Market Trends |
6 Australia Pharmaceutical Granulation Equipment Market, By Types |
6.1 Australia Pharmaceutical Granulation Equipment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Single Pot Granulators, 2021- 2031F |
6.1.4 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By High Sheer Granulators, 2021- 2031F |
6.1.5 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Oscillating Granulators, 2021- 2031F |
6.1.6 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Pharmaceutical Granulation Equipment Market, By Mechanism |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Dry Granulators, 2021- 2031F |
6.2.3 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Wet Granulators, 2021- 2031F |
6.2.4 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Mixture Granulators, 2021- 2031F |
6.3 Australia Pharmaceutical Granulation Equipment Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Pharmaceutical Manufacturing Companies, 2021- 2031F |
6.3.3 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.3.4 Australia Pharmaceutical Granulation Equipment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Pharmaceutical Granulation Equipment Market Import-Export Trade Statistics |
7.1 Australia Pharmaceutical Granulation Equipment Market Export to Major Countries |
7.2 Australia Pharmaceutical Granulation Equipment Market Imports from Major Countries |
8 Australia Pharmaceutical Granulation Equipment Market Key Performance Indicators |
9 Australia Pharmaceutical Granulation Equipment Market - Opportunity Assessment |
9.1 Australia Pharmaceutical Granulation Equipment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Pharmaceutical Granulation Equipment Market Opportunity Assessment, By Mechanism, 2021 & 2031F |
9.3 Australia Pharmaceutical Granulation Equipment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Pharmaceutical Granulation Equipment Market - Competitive Landscape |
10.1 Australia Pharmaceutical Granulation Equipment Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharmaceutical Granulation Equipment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |